Metabolomics: Technologies and Global Markets

Report Code: BIO055E

Publish Date: Jul 2024

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Report Includes

  • 32 data tables and 39 additional tables
  • An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
  • Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
  • Evaluation of the current market’s size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
  • Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
  • A look at ESG trends
  • Information on developments in R&D, clinical trials, emerging technologies, and economic trends
  • Analysis of key companies’ market shares, proprietary technologies, patents, and alliances
  • Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

Report Scope

This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $14.7 billion
Market size forecast $30.2 billion
Growth rate CAGR of 13.1% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Product, Indication, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered China, India, Japan, Malaysia, Singapore U.S., Canada, Mexico, Germany, U.K., France, Italy, and Spain
Key Market Drivers
  • Technological advancements.
  • Increasing healthcare expenditure.
  • Precision medicine and personalized healthcare.
  • Drug discovery and development.
Companies studied
AGILENT TECHNOLOGIES INC.BIO-RAD LABORATORIES INC.
BRUKERDANAHER CORP.
MERCK KGAASHIMADZU CORP.
THERMO FISHER SCIENTIFIC INC.WATERS CORP.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global medical robotics and computer-assisted surgery market is projected to grow from $14.4 billion in 2023 to $30.2 billion in 2029 at a compound annual growth rate (CAGR) of 13.1 % during the forecast period.
The growth of the metabolomics technologies market is propelled by advancements in analytical techniques, expanding applications in clinical research and personalized nutrition, increasing integration into pharmaceutical and biotechnology research, and rising demand in agriculture and food sciences.
The global Metabolomics Technologies market is segmented based on the product type, Indication, application and geographic region.
The surgical robotics systems segment will dominate the market by the end of 2028.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Metabolomics: Technologies and Global Markets99Free
Chapter- 1: Executive Summary3Free
Chapter- 2: Market Overview12Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Emerging Technologies and Developments19Free
Chapter- 5: Market Segmentation Analysis21Free
Chapter- 6: Competitive Intelligence4Free
Chapter- 7: Appendix31Free
Published - Dec-2021| Analyst - BCC Publishing| Code - BIO055D

Report Highlights

The global metabolomics market should reach $22.7 billion by 2026 from $12.7 billion in 2021 at a compound annual growth rate (CAGR) of 12.3% for the forecast period of 2021 to 2026.

Report Includes

  • 59 tables
  • An overview and industry analysis of the global markets for metabolomics technologies
  • Analyses of global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
  • Coverage of history and pathways of metabolomics, information on metabolomes and their sources like large bowel microflora, urine metabolome, food metabolome and comparison between lipidomes and lipidomics
  • Highlights of the market potential for metabolomics market by product, indication, application, and region; assessment of investment in metabolomic research and spending in pharmaceutical and biotech R&D
  • Information on targeted and untargeted approaches for metabolomic technology and complexity associated with data examination and processing
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Detailed profiles of the leading companies in the metabolomics market, including Agilent Technologies, Bio-Rad, Danaher Corp., Merck KGaA, Promega Corp. and Thermo Fisher Scientific
Published - Mar-2019| Analyst - BCC Publishing| Code - BIO055C

Report Highlights

The global market for metabolomics should grow from $9.8 billion in 2018 to reach $17.1 billion by 2023 at a compound annual growth rate (CAGR) of 11.9% for the period of 2018-2023.

Report Includes

  • 86 data tables and 16 additional tables
  • Brief overview and industry analysis of the global markets for metabolomics technologies
  • Analyses of global market trends with data from 2016 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Assessment of the key marketed products and recent product launches, regulatory landscape across different demographics covering North America, Europe, Asia-Pacific, Latin America and Middle East
  • Examination of the main structure of the metabolomics market by segments, key application areas, and market participants
  • Market dynamics and estimated data regarding metabolomics by technological platforms (analytical instruments), detection techniques, separation techniques, assays, disease indication types, applications and geographical regions
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Detailed profiles of the leading companies in the metabolomics market, including LECO Corp., Metabolon Inc., Shimadzu Corp., Thermo Fisher Scientific Inc., and Waters Corp.
Published - Nov-2015| Analyst - Robert Hunter| Code - BIO055B

Report Highlights

The global metabolomic market totaled $5.9 billion in 2014 and should total $6.8 billion in 2015 and $12.5 billion by 2020, registering a compound annual growth rate (CAGR) of 13.0%.

Report Includes

  • An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
  • Analyses of global market trends, with data from 2014, estimates for 2015 and projections of compound annual growth rates (CAGRs) through 2020
  • Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
  • Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
  • Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
  • Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
  • Patent analysis
  • Company profiles of major players in the field
Published - Feb-2013| Analyst - Marianna Tcherpakov| Code - BIO055A

Report Highlights

The global market for metabolomics was valued at $712 million in 2012 and is expect to reach nearly $1.4 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 14.2%.

Report Includes

  • An overview of the commercial potential of the metabolomics research field, the systematic study of the unique chemical fingerprints that cellular processes leaves behind
  • Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Definitions of metabolome, metabolites, and metabolomics vs. metabonomics
  • Discussion of the conceptual approach in metabolomics: target analysis, metabolite profiling, metabolomics, metabolic fingerprinting
  • Examination of the main structure of the metabolomics market: segments, key application areas, and market participants
  • Separation techniques for metabolomics: gas chromatography, capillary electrophoresis, and high-performance liquid chromatography (HPLC)
  • Patent analysis
  • Comprehensive company profiles of major players

Related Reports

Antibody-Drug Conjugates: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - PHM161C

The global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to reach $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Biomarkers: Technologies and Global Markets

Published - Apr 2021 | Publisher - Kamna Jhamb | Code - BIO061F

The global market for biomarkers should grow from $43.3 billion in 2020 to $92.1 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.

Recent Reports

RNA Sequencing: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO147B

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.

Antibody Drugs: Technologies and Global Markets

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO016M

The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.

European Life Science Tools and Reagents Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO262A

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

Global Multiomics Market

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO260A

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Top Trending Reports

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Artificial Intelligence (AI) in Life Sciences Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO255A

The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.

Drug Discovery Technologies

Published - Sep 2024 | Publisher - BCC Publishing | Code - BIO020H

The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.

Synthetic Biology: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO066H

The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.

Gene Editing Therapeutics Market

Published - Aug 2024 | Publisher - BCC Publishing | Code - BIO259A

The report provides an overview of current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also include company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Metabolomics: Technologies and Global Markets
Sample Report